OBIO Completes Successful Canadian Health Investment Showcase in New York City

NEW YORK–(BUSINESS WIRE)–#healthscience–The Ontario Bioscience Innovation Organization (OBIO®) is
honoured to announce the conclusion of the successful Canadian Health
Investment Showcase which took place in New York, NY, on November 5 and
6, 2018.

At the Showcase, 21 representatives from Canada’s highest potential
health science companies and more than 35 premier US investors engaged
in hundreds of meetings and created exciting investment and
collaboration opportunities.

“OBIO is proud of the success of the Canadian Health Investment Showcase
which has demonstrated the incredibly high quality of Canadian health
science companies to US investors,” said Gail Garland, President and CEO
of OBIO. “The success of this showcase reveals the high-quality deal
flow in Canada for US investors and establishes new networks for
Canadian companies in the US.”

Over two days at the Consulate General of Canada in New York, OBIO’s
Canadian Health Investment Showcase profiled elite US investment firms
Aisling Capital and Canaan Partners as well as expertise from Norton
Rose Fulbright and Biotagenics in a robust discussion on the feasibility
of cross-border investing. Silicon Valley Bank provided a keynote
address on trends in health investing this year and Cresco Advisors and
Edison Partners shared investor insights in the digital health space.

“OBIO’s Canadian Health Investment Showcase was a highly effective event
that highlighted both the world-class calibre of Canadian health science
technologies and companies, as well as the opportunity for US investors
in Canada,” said Dennis Purcell, Founder and Senior Advisor at Aisling
Capital. “I look forward to developing the opportunities that have come
out of this event and to working with OBIO in the future.”

As Canadian health science companies scale and grow here, attracting
global capital and building networks of investors is of paramount
importance.

“OBIO’s Canadian Health Investment Showcase was an unprecedented success
for both Canadian health science companies and the industry as a whole,”
said Dr. Jeremy Bridge-Cook, CEO of Rna Diagnostics. “I am proud to have
been part of the delegation of companies at the Canadian Health
Investment Showcase and I congratulate OBIO on delivering an
unparalleled investor event for Canadian companies.”

The Ontario Bioscience Innovation Organization (OBIO®)
founded in 2009, is a not-for-profit, membership-based organization
engaged in strategy, programming, policy development and advocacy to
further the commercialization of Ontario’s human health technologies
positioning Ontario as a leader in the international marketplace. OBIO
advances this goal through collaborative partnerships with industry, the
investment community, academia, the health system and government.

For more information please visit www.obio.ca
and follow OBIO on Twitter @OBIOscience.

Contacts

OBIO
Grant Burns, 416-848-6839 ext. 106
Director,
Public Affairs and Communications
grantburns@obio.ca

leverton

I have been involved with publishing and marketing for the past 32 years. My passion is helping people share their voice. I am able to do this through two important venues: One, with Area-Info.net where people can share everything from opinions to events to news. It is your choice! What do you want to share? Two, through a new program called America's Real Deal I am involved with to help business owners get their voice heard.I schedule speaking engagements with community groups and business groups to share my passion about the importance of "sharing your voice".Contact me directly at lee@leeeverton.coom for scheduling information.